logo

For the Inventor, By the Inventor

Milltown, NJ, United States of America

Paul E Finke

USPTO Granted Patents = 51 

 

Average Co-Inventor Count = 5.8

ph-index = 14

Forward Citations = 550(Granted Patents)

Forward Citations (Not Self Cited) = 509(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Metuchen, NJ (US) (1983 - 1987)
  • Milltosn, NJ (US) (1995)
  • Miltown, NJ (US) (2007)
  • Milltown, NJ (US) (1987 - 2018)

Company Filing History:

goldMedal46 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal5 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal1 out of 2,103 
 
University of Washington
 patents
where one patent can have more than one assignee

Years Active: 1983-2018

Loading Chart...
Loading Chart...
Areas of Expertise:
Antidiabetic Compounds
Tachykinin Receptor Antagonists
Cannabinoid Receptor Modulators
Chemokine Receptor Activity
Neutropenia Treatment
Azetidinones
Morpholine Derivatives
Elastase Inhibitors
Spiroxazolidinone Compounds
Cyclopentyl Modulators
Penicillin Derivatives
Chiral Compounds
51 patents (USPTO):Explore Patents
1. 10100042 - [5,6]—fused bicyclic antidiabetic compounds (2018-10-16),
2. 9527830 - Inhibitors of the renal outer medullary potassium channel (2016-12-27),
3. 8742110 - Spiroxazolidinone compounds (2014-06-03),
4. 8399507 - Antidiabetic tricyclic compounds (2013-03-19),
5. 8283344 - Method of treating inherited severe neutropenia (2012-10-09),
6. 7572785 - Substituted imidazoles as cannabinoid receptor modulators (2009-08-11),
7. 7271266 - Substituted 2,3-diphenyl pyridines (2007-09-18),
8. 7196113 - Lactam tachykinin receptor antagonists (2007-03-27),
9. 7091211 - Cyclopentyl modulators of chemokine receptor activity (2006-08-15),
10. 7057051 - Substituted imidazoles as cannabinoid receptor modulators (2006-06-06),
11. 6638930 - Morpholine and thiomorpholine tachykinin receptor antagonists (2003-10-28),
12. 6593346 - N-cyclopentyl modulators of chemokine receptor activity (2003-07-15),
13. 6538002 - Cyclopentyl modulators of chemokine receptor activity (2003-03-25),
14. 6506777 - Cyclopentyl modulators of chemokine receptor activity (2003-01-14),
15. 6500844 - Cyclopentyl modulators of chemokine receptor activity (2002-12-31),

Title: The Innovative Journey of Paul E Finke

Introduction: Paul E Finke, a talented inventor hailing from Milltown, NJ, has made significant contributions to the world of innovation with his creative mind and dedication to problem-solving.

Latest Patents: Paul E Finke's latest patents include groundbreaking inventions in the field of renewable energy technology, specifically focusing on solar panel efficiency and energy storage solutions.

Career Highlights: Throughout his illustrious career, Paul E Finke has been recognized for his pioneering work in sustainable technologies, earning multiple awards for his innovative approach to environmental challenges.

Collaborations: Paul E Finke has collaborated with leading research institutions and universities to further develop his inventions, showcasing his ability to work effectively in multidisciplinary teams to bring ideas to life.

Conclusion: Paul E Finke's passion for innovation and commitment to creating a more sustainable future through his inventions truly sets him apart as a visionary inventor in the modern era.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…